Effective April 13, 2015, Baylor Miraca Genetics Laboratories will discontinue the following tests:
- Test Code: 6685 – TPMT Sequence Analysis
- Test Code: 6870 – Cytochrome P450 2C19 (CYP2C19) Genotyping
- Test code: 6875 – Cytochrome P450 2D6 (CYP2D6) Genotyping
- Test code: 6880 – Warfarin Sensitivity Genotyping
Baylor Genetics is a joint venture of H.U. Group Holdings and the #1 NIH-funded genetics program at Baylor College of Medicine. A pioneer of precision medicine for nearly 40 years, Baylor Genetics now offers a full spectrum of clinically relevant genetic testing, access to world-renowned experts, and the confidence to provide patients with the best care. Baylor Genetics, located in Houston’s Texas Medical Center, serves clients in 50 states and 16 countries.